Cancer RNAs and Epigenetic group
The Cancer RNAs and Epigenetic research group studies the mechanisms of genome regulation and plasticity in cancer, with the goal to impact cancer progression and treatment.
ACTIVITIES
Epigenetic modifications and RNA regulation are critical to establish and maintain cellular identity and function. Dysregulation in these processes can reprogram cancer cells, enabling them to evade immune surveillance, exploit normal physiological processes for growth and spread, and resist therapies.
The Cancer RNAs and Epigenetic research group focuses on the understanding of the complex interplay between genome organization and its expression in cancer, particularly in brain tumors. We apply cutting-edge approaches and integrative biology, to identify novel gene therapeutic targets and decipher molecular mechanisms underlying cancer features. By gaining deeper insights into how cancer cells operate and adapt to their environment through epigenome rewiring, our ultimate goal is to foster the development of more effective treatment strategies. We are particularly interested in harnessing the power of RNA molecules and gene editing applications for precision medicine.
OUR FOCUS AREAS
- Epigenetic and Long non-coding RNAs
- Epitranscriptomics
- RNA therapeutics and genome editing for precision medicine
Fritah
Discover Dr Fritah’s profile on our Research Portal.
Partners & Funding
Projects & clinical trials
Featured team members
-
Sabrina
Fritah Group Leader -
Mélanie
Vausort Research Engineer
Scientific publications
Job vacancies
-
PhD Student in Cancer Epigenetics (JA/PHD0125/SF/CREG)
Department of Cancer Research – Cancer RNAs & Epigenetic Group